Carcinoma in situ refers to cancer in which abnormal cells have not spread beyond where they were first formed. In this presentation, breast cancer surgeon Dr Cindy Mak discusses the nature of in-situ vs invasive cancer addressing the types of in-situ cancer, diagnoses, management and treatment.
- Understand the difference between invasive and in-situ breast cancer
- Understand the difference between DCIS (docular) and LCIS (lobular)
- Outline what imaging is required and how to biopsy
- Discuss what treatment patients can expect and who can avoid treatment
Chris O’Brien Lifehouse is a not-for-profit, comprehensive cancer hospital in Camperdown, Sydney. From screening to prevention, diagnosis, treatment and wellness, they treat all types of cancer, specialising in those that are complex and rare. They offer patients every service and therapy that they need including surgery, chemotherapy, radiation therapy, complementary therapies and supportive services, all under the one roof. Their mission is to improve the quality of life of cancer patients, carers and their families by advancing the understanding, diagnosis, treatment, cure and prevention of the disease.
Expert: Dr Cindy Mak
Dr Cindy Mak is Director of Breast Services at Chris O’Brien Lifehouse. She also operates at the Mater Hospital (North Sydney) and Royal Prince Alfred Hospital. Cindy is a Visiting Medical Officer at BreastScreen NSW, a member of the Australasian Society for Breast Disease, the ANZ Breast Cancer Trials Group, the Australian Medical Association and is an honorary scientific officer at The Garvan Institute. She is the current chair of the oncoplastic subcommittee of Breast SurgANZ. She has a role in national policy making and has been involved in Cancer Australia media statements and policy.
Carcinoma in-situ of the Breast (20 mins of CPD)
Test your learning!